Prime Medicine Inc Sustainability Reports
Prime Medicine, Inc. is a biotechnology company focused on commercializing Prime Editing technology to deliver one-time curative genetic therapies for severe monogenic diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG011RT3R64
3 reports from 2022 to 2024
Company Profile
Prime Medicine, Inc. is a biotechnology company focused on commercializing Prime Editing technology to deliver one-time curative genetic therapies for severe monogenic diseases.
Reports
3 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
